Which imaging modality is commonly used to detect distant metastases in lung cancer for staging?

Which imaging modality is commonly used to detect distant metastases in lung cancer for staging?

• A. PET-CT
• B. CT chest
• C. MRI brain
• D. Ultrasound abdomen

Answer: (A)

Detecting distant metastases is essential for accurate staging in lung cancer, because finding metastatic spread upstages the disease (M stage) and shifts management toward systemic or palliative approaches rather than curative intent. PET-CT is the modality that provides the most comprehensive whole-body survey, combining metabolic information with anatomic detail. The radiotracer (FDG) highlights areas of increased glucose metabolism typical of cancer, allowing the detection of metastases in the liver, bones, adrenal glands, distant lymph nodes, and other sites in a single study. This often reveals disease that would be missed by imaging focused only on the chest, and it helps tailor treatment plans, avoid unnecessary procedures, and determine prognosis. While MRI of the brain is more sensitive for identifying brain metastases and targeted imaging like CT chest or ultrasound abdomen can assess specific regions, they don’t offer the systemic overview that PET-CT provides for distant disease. Therefore, PET-CT is the commonly used tool for detecting distant metastases during staging.

Detecting distant metastases is essential for accurate staging in lung cancer, because finding metastatic spread upstages the disease (M stage) and shifts management toward systemic or palliative approaches rather than curative intent. PET-CT is the modality that provides the most comprehensive whole-body survey, combining metabolic information with anatomic detail. The radiotracer (FDG) highlights areas of increased glucose metabolism typical of cancer, allowing the detection of metastases in the liver, bones, adrenal glands, distant lymph nodes, and other sites in a single study. This often reveals disease that would be missed by imaging focused only on the chest, and it helps tailor treatment plans, avoid unnecessary procedures, and determine prognosis. While MRI of the brain is more sensitive for identifying brain metastases and targeted imaging like CT chest or ultrasound abdomen can assess specific regions, they don’t offer the systemic overview that PET-CT provides for distant disease. Therefore, PET-CT is the commonly used tool for detecting distant metastases during staging.